Bush nominee for head of FDA could be installed by year's end. (Washington).(Brief Article)

Food Institute Report, The, August, 2002

When the Bush Administration came to power, the White House had an agenda of selecting a commissioner for the Food & Drug Administration who would be the opposite of Dr. David A. Kessler, the FDA chief who campaigned against Big Tobacco and was a "fly in the ointment" of Bush Sr., reported Business Week (Aug. 5).

To fill the 18-month void, the Administration is expected to nominate Dr. Mark B. McClellan, age 39, a highly respected health-care economist at Stanford University and current member of the President's Council of Economic Advisers. Regarded as low-key, largely apolitical and smart, McClellan could be on the job by the end of the year. His academic studies examine the cost-effectiveness of new health-care innovations.

His agenda as FDA chief...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.